NUS1P2

Across TCGA pan-cancer cohorts, NUS1P2 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated NUS1P2 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher NUS1P2 RNA is associated with better overall survival. In most high-consensus cancer types, elevated NUS1P2 expression acts as an unfavorable survival marker, although some lineages such as BRCA and KIRC show a favorable association.

BRCA, KIRC, and KICH are the cancer types where NUS1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	IV	0.950	0.319	.001	96	view →
KIRC	DFS	Median	IV	0.744	0.481	<.001	46	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	39	view →
LUAD	DFS	Median	All	0.733	0.884	<.001	37	view →
ESCA	OS	Quartile	All	0.769	0.541	.004	34	view →
ACC	OS	Quartile	III,IV	0.324	0.704	.001	29	view →
THCA	DFS	Tertile	All	0.774	0.915	.007	21	view →
SKCM	OS	Quartile	II,III,IV	0.752	0.866	.002	18	view →
KIRP	OS	Quartile	All	0.979	0.866	.003	18	view →
LAML	DFS	Tertile	All	0.367	0.626	.012	18	view →
LGG	OS	Tertile	All	0.933	0.822	<.001	17	view →
READ	OS	Tertile	All	0.827	0.945	.016	17	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

NUS1P2–BRCA (OS)

Open the BRCA breakdown →